KEVELT AS
Bankrupt Registry code 10418580
AS Tallinn Registered 24 Mar 1998
KEVELT AS is a AS based in Tallinn, registry code 10418580, status: bankrupt. Main activity: Manufacture of pharmaceutical preparations. According to EMTA, turnover for Q3 2026 was €0 with employees.
Turnover
0 €
↓ 100.0% vs Q2 2026
State taxes
—
Labour taxes
—
Employees
—
Q3 2026 · data from the Tax and Customs Board (EMTA)
Position in the industry
- Revenue · 2025 2 mn €above 75% of companiesindustry median 48 003 € · companies in the industry: 19
- Net profit margin · 2025 -46.4 %above 15% of companiesindustry median 9.8 % · companies in the industry: 15
Taxes and turnover
- Company
- Industry median
Industry: Manufacture of basic pharmaceutical products and pharmaceutical preparations (the EMTAK division of the main activity). Median: half of the industry is above, half below.
- Company
- Industry median
Industry: Manufacture of basic pharmaceutical products and pharmaceutical preparations (the EMTAK division of the main activity). Median: half of the industry is above, half below.
| Quarter | Turnover, € | State taxes, € | Labour taxes, € | Employees |
|---|---|---|---|---|
| Q3 2026 | — | — | — | — |
| Q2 2026 | 968 112 | 5 113 | 8 641 | — |
| Q1 2026 | 894 116 | 106 476 | 112 616 | 38 |
| Q4 2025 | 834 913 | 143 282 | 151 163 | 37 |
| Q3 2025 | 545 634 | 105 190 | 113 831 | 36 |
| Q2 2025 | 789 285 | 145 215 | 152 044 | 37 |
| Q1 2025 | 913 828 | 191 190 | 198 774 | 37 |
| Q4 2024 | 1 340 806 | 63 863 | 71 080 | 35 |
| Q3 2024 | 382 989 | 109 002 | 115 063 | 36 |
| Q2 2024 | 913 503 | 87 604 | 92 330 | 34 |
| Q1 2024 | 644 445 | 76 778 | 82 026 | 36 |
| Q4 2023 | 978 397 | 138 335 | 142 517 | 33 |
| Q3 2023 | 498 788 | 138 808 | 143 425 | 32 |
| Q2 2023 | 868 188 | 106 261 | 109 979 | 30 |
| Q1 2023 | 190 607 | 90 787 | 94 514 | 29 |
| Q4 2022 | 773 050 | 77 829 | 80 820 | 29 |
| Q3 2022 | 636 915 | 92 205 | 95 989 | 28 |
| Q2 2022 | 884 940 | 67 167 | 72 276 | 31 |
| Q1 2022 | 676 057 | 73 834 | 78 399 | 34 |
Financials by year
- Company
- Industry median
Industry: Manufacture of basic pharmaceutical products and pharmaceutical preparations (the EMTAK division of the main activity). Median: half of the industry is above, half below.
- Company
- Industry median
Industry: Manufacture of basic pharmaceutical products and pharmaceutical preparations (the EMTAK division of the main activity). Median: half of the industry is above, half below.
- Company
- Industry median
Industry: Manufacture of basic pharmaceutical products and pharmaceutical preparations (the EMTAK division of the main activity). Median: half of the industry is above, half below.
- Company
- Industry median
Industry: Manufacture of basic pharmaceutical products and pharmaceutical preparations (the EMTAK division of the main activity). Median: half of the industry is above, half below.
| Year | Revenue, € | Net profit, € | Labour costs, € | Assets, € | Equity, € | Employees |
|---|---|---|---|---|---|---|
| 2025 | 1 998 168 | -927 977 | 1 373 097 | 999 138 | 174 979 | 31 |
| 2024 | 2 337 880 | 27 321 | 1 285 155 | 1 927 483 | 1 102 956 | 32 |
| 2023 | 2 544 589 | -25 717 | 1 088 584 | 5 646 259 | 1 082 025 | 27 |
| 2022 | 2 255 486 | -394 338 | 941 271 | 5 786 439 | 1 107 742 | 26 |
| 2021 | 2 720 817 | -178 562 | 951 191 | 6 184 182 | 1 502 080 | 31 |
| 2020 | 2 505 547 | -1 302 981 | 947 684 | 5 794 744 | 1 680 642 | 31 |
| 2019 | 2 818 384 | 1 368 657 | 982 543 | 12 052 626 | 9 072 782 | 36 |
| 2018 | — | — | — | — | — | 37 |
| 2017 | — | — | — | — | — | 38 |
| 2016 | — | — | — | — | — | 33 |
| 2015 | — | — | — | — | — | 38 |
| 2014 | — | — | — | — | — | 42 |
| 2013 | — | — | — | — | — | 31 |
| 2012 | — | — | — | — | — | 21 |
| 2011 | — | — | — | — | — | 17 |
| 2010 | — | — | — | — | — | 16 |
| 2009 | — | — | — | — | — | 12 |
| 2008 | — | — | — | — | — | 12 |
| 2007 | — | — | — | — | — | 12 |
| 2005 | — | — | — | — | — | 10 |
| 2004 | — | — | — | — | — | 10 |
| 2003 | — | — | — | — | — | 10 |
| 2002 | — | — | — | — | — | 10 |
| 2001 | — | — | — | — | — | 10 |
| 2000 | — | — | — | — | — | 10 |
| 1999 | — | — | — | — | — | 8 |
| 1998 | — | — | — | — | — | 7 |
| 1997 | — | — | — | — | — | 4 |
Figures from the company’s own (non-consolidated) balance sheet and income statement. A loss is shown with a minus sign.
Financial ratios for 2025
Net profit margin
-46.4 %
Net profit / revenue
Return on equity (ROE)
-530.3 %
Net profit / equity
Return on assets (ROA)
-92.9 %
Net profit / assets
Equity ratio
17.5 %
Equity / assets
Debt ratio
82.5 %
Liabilities / assets
Current ratio
1.07
Current assets / current liabilities
Revenue per employee
64 457 €
Revenue / average full-time employees
Labour cost per employee per month
3 691 €
Labour costs / employees / 12 months (incl. employer taxes)
Annual reports
| Year | Period | Filed | Report | Documents |
|---|---|---|---|---|
| 2025 | 1 Jan 2025 – 31 Dec 2025 | 20 Feb 2026 | Company’s own | e-Äriregister |
| 2024 | 1 Jan 2024 – 31 Dec 2024 | 9 Feb 2026 | Company’s own · audited | e-Äriregister |
| 2023 | 1 Jan 2023 – 31 Dec 2023 | 26 Apr 2024 | Company’s own · audited | e-Äriregister |
| 2022 | 1 Jan 2022 – 31 Dec 2022 | 15 Jun 2023 | Company’s own · audited | e-Äriregister |
| 2021 | 1 Jan 2021 – 31 Dec 2021 | 6 Jun 2022 | Company’s own · audited | e-Äriregister |
| 2020 | 1 Jan 2020 – 31 Dec 2020 | 1 Jun 2021 | Company’s own · audited | e-Äriregister |
| 2019 | 1 Jan 2019 – 31 Dec 2019 | 17 Jun 2020 | Company’s own · audited | e-Äriregister |
Board
- Nasdaq CSD SEKeeper of the share ledger · since 27 Sep 2017
- Indrek LepsooBankruptcy trustee · since 13 Aug 2026
Owners
No owner information.
Owner in
- 1.93%
Beneficial owners
- DMITRY GENKINDirect ownership · ITA · since 21 Oct 2024
Founders and other persons
- AVL Audiitorteenuste OÜAudit firm · 16 Dec 2025
- Kirill SurkovChairman of the supervisory board · 17 Apr 2026
- Sergey AvtushenkoSupervisory board member · 25 Sep 2024
- Dmitry GenkinSupervisory board member · 17 Apr 2026
- Omanikukonto: DMITRY GENKINShareholder · 121 410 € · 5 Mar 2025
Related companies
Activities (EMTAK)
- 21201Manufacture of pharmaceutical preparations Main
- 74991All other professional, scientific and technical activities n.e.c.
History of changes
| What | Value | Period |
|---|---|---|
| Status | Bankrupt | 13 Aug 2026 – now |
| Status | Active | 24 Mar 1998 – now |
Rulings
All rulings (PDF)| Number, date | Title | Deadline | State | Document |
|---|---|---|---|---|
| Ä 10028858 / 37 13 Aug 2026 |
Entry to enforce another court decision | In force 13 Aug 2026 |
||
| Ä 10028858 / 36 14 May 2026 |
Amendment entry | In force 14 May 2026 |
||
| Ä 10028858 / M24 17 Apr 2026 |
Ruling to eliminate deficiencies | 17 May 2026 | Deficiencies eliminated 17 Apr 2026 |
|
| Ä 10028858 / 35 17 Apr 2026 |
Amendment entry | In force 17 Apr 2026 |
||
| Ä 10028858 / M23 1 Sep 2025 |
Procedural ruling | In force 1 Sep 2025 |
||
| Ä 10028858 / M22 10 Jul 2025 |
Warning of a fine: annual report not filed | 9 Aug 2025 | In force 10 Jul 2025 |
|
| Ä 10028858 / M21 26 May 2025 |
Ruling to correct data outside an entry | 9 Jun 2025 | Deficiencies eliminated 4 Jun 2025 |
|
| Ä 10028858 / 34 26 Feb 2025 |
Division entry (second, constitutive) | In force 26 Feb 2025 |
||
| Ä 10028858 / 33 21 Nov 2024 |
Amendment entry | In force 21 Nov 2024 |
||
| Ä 10028858 / 32 10 Jul 2023 |
Amendment entry | In force 10 Jul 2023 |
||
| Ä 10028858 / M20 26 Jun 2023 |
Procedural ruling | 17 Jul 2023 | Deficiencies eliminated 6 Jul 2023 |
|
| Ä 10028858 / M19 2 Jun 2023 |
Ruling to eliminate deficiencies | 29 Jun 2023 | Deficiencies eliminated 6 Jul 2023 |
|
| Ä 10028858 / 31 9 Jan 2023 |
Amendment entry | In force 9 Jan 2023 |
||
| Ä 10028858 / 30 1 Oct 2020 |
Amendment entry | In force 1 Oct 2020 |
||
| Ä 10028858 / 29 4 Jun 2020 |
Amendment entry | In force 4 Jun 2020 |
||
| Ä 10028858 / M18 2 Jun 2020 |
Ruling to eliminate deficiencies | 17 Jun 2020 | Deficiencies eliminated 4 Jun 2020 |
|
| Ä 10028858 / 28 9 Mar 2020 |
Amendment entry | In force 9 Mar 2020 |
||
| Ä 10028858 / 27 6 Nov 2018 |
Amendment entry | In force 6 Nov 2018 |
||
| Ä 10028858 / 26 16 Jan 2018 |
Amendment entry | In force 16 Jan 2018 |
||
| Ä 10028858 / 25 11 Dec 2017 |
Amendment entry | In force 11 Dec 2017 |
||
| Ä 10028858 / M17 30 Nov 2017 |
Ruling to eliminate deficiencies | 15 Dec 2017 | Deficiencies eliminated 7 Dec 2017 |
|
| Ä 10028858 / 24 7 Nov 2017 |
Amendment entry | In force 7 Nov 2017 |
||
| Ä 10028858 / 23 27 Sep 2017 |
Amendment entry | In force 27 Sep 2017 |
||
| Ä 10028858 / 22 12 Sep 2016 |
Amendment entry | In force 12 Sep 2016 |
||
| Ä 10028858 / 21 12 Aug 2016 |
Amendment entry | In force 12 Aug 2016 |
||
| Ä 10028858 / M16 20 Jul 2016 |
Ruling to eliminate deficiencies | 24 Aug 2016 | Deficiencies eliminated 12 Aug 2016 |
|
| Ä 10028858 / M15 16 Jun 2016 |
Ruling to eliminate deficiencies | 16 Jul 2016 | Deficiencies eliminated 12 Aug 2016 |
|
| Ä 10028858 / 20 28 Apr 2015 |
Amendment entry | In force 28 Apr 2015 |
||
| Ä 10028858 / M14 27 Apr 2015 |
Ruling to eliminate deficiencies (to be served) | 29 Oct 2015 | Deficiencies eliminated 28 Apr 2015 |
|
| Ä 10028858 / M13 24 Apr 2015 |
Ruling to eliminate deficiencies | 24 May 2015 | Deficiencies eliminated 28 Apr 2015 |
|
| Ä 10028858 / 19 27 Jan 2015 |
Amendment entry | In force 27 Jan 2015 |
||
| Ä 10028858 / M12 29 Dec 2014 |
Ruling to eliminate deficiencies | 28 Jan 2015 | Deficiencies eliminated 23 Jan 2015 |
|
| Ä 10028858 / 18 4 Nov 2014 |
Amendment entry | In force 4 Nov 2014 |
||
| Ä 10028858 / M11 8 Oct 2014 |
Ruling to eliminate deficiencies | 7 Nov 2014 | Deficiencies eliminated 4 Nov 2014 |
|
| Ä 10028858 / 17 11 Jun 2014 |
Amendment entry | In force 11 Jun 2014 |
||
| Ä 10028858 / M10 12 May 2014 |
Ruling to eliminate deficiencies | 11 Jun 2014 | Deficiencies eliminated 4 Jun 2014 |
|
| Ä 10028858 / 16 27 Jan 2014 |
Amendment entry | In force 27 Jan 2014 |
||
| Ä 10028858 / M9 3 Jan 2014 |
Ruling to correct data outside an entry | 2 Feb 2014 | Deficiencies eliminated 7 Jan 2014 |
|
| Ä 10028858 / 15 27 Jun 2013 |
Amendment entry | In force 27 Jun 2013 |
||
| Ä 10028858 / M8 25 Jun 2013 |
Ruling to eliminate deficiencies | 9 Aug 2013 | Deficiencies eliminated 26 Jun 2013 |
|
| Ä 10028858 / 14 8 May 2013 |
Amendment entry | In force 8 May 2013 |
||
| Ä 10028858 / M7 6 May 2013 |
Ruling to eliminate deficiencies | 5 Jun 2013 | Deficiencies eliminated 8 May 2013 |
|
| Ä 10028858 / 13 10 Apr 2012 |
Amendment entry | In force 10 Apr 2012 |
||
| Ä 10028858 / M6 26 Mar 2012 |
Ruling to eliminate deficiencies | 15 May 2012 | In force 26 Mar 2012 |
|
| Ä 10028858 / 12 1 Mar 2012 |
Amendment entry | In force 1 Mar 2012 |
||
| Ä 10028858 / M5 20 Feb 2012 |
Ruling to eliminate deficiencies | 14 Mar 2012 | In force 20 Feb 2012 |
|
| Ä 10028858 / M4 13 Jan 2012 |
Ruling to eliminate deficiencies | 1 Mar 2012 | In force 13 Jan 2012 |
|
| Ä 10028858 / 11 7 Jan 2011 |
Amendment entry | In force 7 Jan 2011 |
||
| Ä 10028858 / 10 22 Dec 2010 |
Amendment entry | In force 22 Dec 2010 |
||
| Ä 10028858 / M3 20 Dec 2010 |
Ruling to eliminate deficiencies | 7 Feb 2011 | In force 20 Dec 2010 |
|
| Ä 10028858 / 9 8 Apr 2010 |
Amendment entry | In force 8 Apr 2010 |
||
| Ä 28858 / 8 15 Dec 2009 |
Amendment entry | In force 15 Dec 2009 |
||
| Ä 28858 / 7 10 Nov 2009 |
Amendment entry | In force 10 Nov 2009 |
||
| Ä 28858 / 6 2 Nov 2009 |
Amendment entry | In force 2 Nov 2009 |
||
| Ä 28858 / 5 30 Oct 2009 |
Amendment entry | In force 30 Oct 2009 |
||
| Ä 28858 / M2 1 Oct 2009 |
Ruling to eliminate deficiencies | 2 Nov 2009 | In force 1 Oct 2009 |
|
| Ä 28858 / 4 3 Dec 2008 |
Deletion of activities from the registry card | In force 8 Dec 2008 |
||
| Ä 28858 / 3 13 Jan 2003 |
Entry decision on the register’s own initiative | In force |
Sources: e-Äriregister and EMTA. Data updated 31 Oct 2026. Open at the source ↗ · Report an error in the data